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ABSTRACT 
Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Symptoms 
sometimes begin after a physical trauma, surgery, infection or significant psychological stress. In other cases, symptoms gradually accumulate over 
time with no single triggering event. 
Women are much more likely to develop fibromyalgia than are men. Many people who have fibromyalgia also have tension headaches, temporo-
mandibular joint (TMJ) disorders, irritable bowel syndrome, anxiety and depression. 
Fibromyalgia is one of the most common chronic pain conditions. The disorder affects an estimated 10 million people in the U.S. and an estimated 3-
6% of the world population. While it is most prevalent in women - 75-90 percent of the people who have fibromyalgia are women - it also occurs in 
men and children of all ethnic groups. The disorder is often seen in families, among siblings or mothers and their children. The diagnosis is usually 
made between the ages of 20 to 50 years, but the incidence rises with age so that by age 80, approximately 8% of adults meet the American College 
of Rheumatology classification of fibromyalgia. 
While there is no cure for fibromyalgia, a variety of medications can help control symptoms. In general, treatments for fibromyalgia include both 
medication and self-care. The emphasis is on minimizing symptoms and improving general health. Medications can help reduce the pain of 
fibromyalgia and improve sleep. Common choices include: Analgesics (Tramadol). In this article we like to discuss on the similarity of action 
between the analgesic medicine (Tramadol) and the homoeopathic medicine Poison oak (Rhus toxicodendron) on fibromyalgia from the 
aetiopathogenetic point of view. Poison oak, a wild growing plant of the anacardiacea family is widely distributed and easily accessible and also a 
very common Homoeopathic remedy as Rhus toxicodendron. 
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INTRODUCTION 
Fibromyalgia (FM) is a syndrome characterized by medically 
unexplained, widespread musculoskeletal pain, hyperalgesia and/or 
allodynia, physical and mental fatigue and effort intolerance, non-
restorative sleep, mood disturbance as well as other functional (e.g. 
gastrointestinal) complaints. [1] 
Although the exact aetio-pathogenesis of FM is not known, the 
precipitating and predisposing role of physical and psychosocial 
stress are responsible in the development of FM. Several 
retrospective case-control studies have shown that traumatic 
experiences (neglect, maltreatment or abuse) during childhood are 
more frequently reported by FM patients than by medically ill or 
healthy controls. [2]. 
Stress and Fibromyalgia 
A current paradigm to explain the complexity of FM symptomatology 
proposes that it is a “stress related syndrome” in which a disordered 
hypothalamic-pituitary-adrenal (HPA) axis acts as a final common 
pathway linking FM to other “stress-related” somatic and psychiatric 
syndromes. [3]  
Stress causes Sleep disorders. FM is seen in particularly those 
patients have an abnormal sleep pattern involving stages 3 and 4 of 
non REM sleep [4]. The Growth Hormone (GH) is secreted 
predominantly during stages 3 and 4 of non-REM sleep. There are 
close links between the Hypothalamo-Pituitary Axis (HPA) and the 
HP-growth hormone (GH) axis.  The Growth hormone is the only 
pituitary hormone that is under the influence of both stimulatory 
and inhibitory hypothalamic hormones. The normal pulsatile 
secretion of GH depends on the tonic balance of stimulatory growth 
hormone releasing hormone (GHRH) and inhibitory somatostatin 
(SRIF). [5]   Under normal circumstances the production of GH 
occurs only when the secretion of GHRH takes place in the setting of 
low levels of somatostatin tone .[6]  Thus the regulation of GH 
secretion is dependent on the relative amounts of GHRH and 
somatostatin that are released from the hypothalamus into the 
hypothalamic-hypophyseal portal venous system.  
Now under the stress there is dysregulation of HPA axis, as a result 
deficiency of GHRH and finally deficiency of secretion of GH. 
On the other hand, many biological “stresses” such as severe 
exercise, trauma and haemorrhage lead to an increase in plasma 
glucocorticoid concentration resulting from release of CRH 
(Corticotrophin-releasing hormone) from the hypothalamus. This 
natural hormone (CRH) is only one of a number of natural and 
synthetic corticotrophin-releasing factors (CRF) which can promote 
the release of ACTH (Adreno-corticotrophic hormone) from the 
anterior pituitary [7] 
Neeck has hypothesized that a stress induced increase in CRF is the 
common denominator linking the disturbed HPA axis and reduced 
GH secretion in FM [8]. 
There is a critical link between the increases CRF and hypothalamic 
somatostatin tone [9]. Increase somatostatin (other name is growth 
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hormone-release inhibiting hormone) inhibits the GHRH and also 
reduces GH secretion. 
Growth hormone deficiency in adults has been associated with a 
miscellany of symptoms that are similar to those described by 
FM patients: low energy, poor general health, reduced exercise 
capacity, muscle weakness, cold intolerance, impaired cognition, and 
decreased body mass.  GH is important in maintaining muscle 
homeostasis, and it was theorized that sub-optimal levels might be a 
factor in the impaired resolution of muscle micro-trauma in FM 
patients. [10]  
Role of Glucocorticoids in the development of fibromyalgia:  
Glucocorticoids (mainly cortisol) accelerate gluconeogenesis in the 
liver, mainly by favouring glycogen formation from amino acids 
formed by protein breakdown. The protein in question may come 
partly from peripheral tissues e.g. muscle. As a result wasting of the 
muscle the patient feels pain. [7] 
Most common medicine used in modern medicine for 
Fibromyalgia:  
ULTRAM® or Tramadol hydrochloride. [11] 
Pharmacology of Ultram (tramadol hydrochloride): 
ULTRAM® (Tramadol hydrochloride) contains tramadol, a centrally 
acting synthetic opioid analgesic. Although its mode of action is not 
completely understood, from animal tests, at least two 
complementary mechanisms appear applicable: binding of parent 
and M1 metabolite to μ-opioid receptors and weak inhibition of re 
uptake of norepinephrine and Serotonin. (The 
catecholamine norepinephrine is a neuro-modulator of the 
peripheral sympathetic nervous system but is also present in the 
blood mostly through "spill over" from the synapses of the 
sympathetic system). [12] 
So, the main action of the ULTRAM® is inhibition of nor- 
epinephrine and serotonin which are responsible for production of 
pain in FM. 
 
Fig. 1. Chemical structure of urushiols found in resin canals of 
poison oak and poison ivy. Poison ivy mostly contains a mixture of 
four pentadecylcatechols (with 15-carbon side chain), while poison 
oak contains a mixture of four heptadecylcatechols (with 17-carbon 
side chain).Now raw Poison oak juice can produce the symptoms 
like of FM (Pain, joint stiffness etc.) because presence of the 
catechols.   
The action of Poison oak on Fibromyalgia 
Freshly cut stem of Rhus toxicodendron (RT) showing adventitious 
roots and black lacquer oozing from resin canals in the inner bark. 
The resinous sap is produced in resin canals of the stems, roots, 
leaves and flowers. J.H. Langenheim (2003) discusses resins of the 
sumac family (Anacardiaceae) in her book entitled Plant Resins: 
Chemistry, Evolution, Ecology, and Ethno botany. Cross sections of 
RT stems show distinct concentric annual rings (ring-porous wood). 
Numerous resin canals appear as tiny black dots and are confined to 
the phloem layer just inside the bark which principally contains 
urushiol responsible for giving poison oak its bad reputation due to 
its involvement in promoting allergic reaction. The name is derived 
from "urushi," Japanese name for lacquer made from the sap of the 
Japanese lacquer tree ("kiurushi" or "urushi ki"). [13] Urushiol is a 
transparent, non volatile olioresin which turns into a brownish 
lacquer when oxidized. It is basically a mixture of phenolic 
compounds called catechols. [14] [A catecholamine (CA) is 
a monoamine, an organic compound that has 
a catechol (benzene with two hydroxyl side groups) and a side 
chain amine][15], potent benzene ring compounds with a long side-
chain of 15 or 17 carbon atoms (Figure 1). According to Dawson-The 
side chain may be saturated or unsaturated with one, two, or three 
double bonds. The remarkable immune reaction and specificity of 
the catechol molecule is determined by the long side-chain. [16] 
Poison oak urushiol contains mostly catechols with 17 carbon side-
chains (heptadecylcatechols), while poison ivy and poison sumac 
contain mostly 15 carbon side-chains (pentadecylcatechols).  See 
Figure 1 below 
Now in the homoeopathic preparation of RT it is serially diluted and 
potentized and then its symptom producing capability is assessed 
through a procedure known as ‘proving’. Homoeopathy stands on 
the law “Similia Similibus Curantur”. It means which can produce 
the disease in crude form the same can cure the same disease in its 
potentized form (This law was established by Hahnemann in 1796, 
after proving of Chinchonabark on himself which produced malaria 
like symptoms in crude form. [17] For this reason when RT is applied 
on the patient of FM then it relieves the pain because then it blocks 
the action of catecholamines. 
“Double blind trials have been conducted using the homeopathic 
remedy Rhus Tox, and according to a report submitted by the 
Complimentary and Alternative (CAM) Review Board in September 
2009, results are promising. Reports indicate that fibromyalgia 
patients taking the remedy have experienced a significant reduction 
in pain, stiffness and weakness from fibromyalgia pain. Rhus Tox is 
well known for the treatment of musculoskeletal conditions. Rhus 
Tox is available at health food stores and may be administered at 
home, but patients should see a qualified homeopath for suggestions 
concerning frequency and dosage.” [18] 
“Rhus tox also induces pains, apparently of a rheumatic kind and 
which are felt not only in the limbs but in the body though most 
especially about the joints. The structures most powerfully affected 
appear to be the fibrous ones. The pains in questions are 
accompanied by a very slight amount of swelling, singular to say, 
they become intensified by rest and warmth. Sleep is greatly 
disturbed, and the patient becoming restless, constantly turning 
about and often suffering from great nervous depression.” [19] 
CONCLUSION 
Fibromyalgia remains a challenging condition. However, clinical 
studies have demonstrated that fibromyalgia patients can reduce 
their symptoms through a variety of treatment options. After the 
above discussion it is clear that analgesic medicine Ultram® and the 
homoeopathic medicine Rhus toxicodendron act on the same plane 
i.e. blocking the pain modulator catecholamines and thereby 
establishing is a similarity in their modus operandi. 
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